A successful pharma-provider partnership is crucial to delivering cell and gene therapy (CGT). However, providers delivering CGT report several challenges to these partnerships, especially during contract negotiation and drug onboarding. This guide provides four recommendations that CGT developers can implement to strengthen their partnerships and address these challenges.